IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin.
J Hematol Oncol. 2021 Jul 29;14(1):118. doi: 10.1186/s13045-021-01128-9.
J Hematol Oncol. 2021.
PMID: 34325726
Free PMC article.
Clinical Trial.